Mirae Asset Global Investments’s Amedisys AMED Stock Holding History

Mirae Asset Global Investments’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-192	Closed	-$18.9K	–	1643
2025 Q2	$18.9K	Sell	192 -11	-5%	-$1.04K	﹤0.01%	1406
2025 Q1	$18.8K	Buy	+203	New	+$18.7K	﹤0.01%	1394
2021 Q3	–	Sell	-1,040	Closed	-$255K	–	1737
2021 Q2	$255K	Buy	1,040 +113	+12%	+$29.6K	﹤0.01%	1611
2021 Q1	$245K	Sell	927 -256	-22%	-$72.2K	﹤0.01%	1458
2020 Q4	$347K	Buy	1,183 +160	+16%	+$41K	﹤0.01%	1408
2020 Q3	$242K	Sell	1,023 -422	-29%	-$95.9K	﹤0.01%	1387
2020 Q2	$287K	Buy	+1,445	New	+$270K	﹤0.01%	1300

Other funds holding AMED

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

MCI

MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Mirae Asset Global Investments's AMED Position: Q3 2025 in Review

Mirae Asset Global Investments sold out of Amedisys (AMED) in Q3 2025, closing a stake of 192 shares — an estimated $18.9K sold.

Mirae Asset Global Investments first reported a position in AMED in Q2 2020 and held it in 7 quarters. The position peaked at $347K in Q4 2020. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

Mirae Asset Global Investments reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
Mirae Asset Global Investments sold 192 Amedisys shares in Q3 2025, an estimated $18.9K.
Mirae Asset Global Investments first reported a position in Amedisys in Q2 2020 and held it in 7 quarters.
Mirae Asset Global Investments's Amedisys position peaked at $347K in Q4 2020.
4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Mirae Asset Global Investments's 13F filing for Q3 2025, filed 3 Nov 2025.